[PHARMA] YoY Annualized Quarter Result on 30-Jun-2018 [#2]

Stock

[PHARMA] PHARMANIAGA BHD

Announcement Date

17-Aug-2018

Admission Sponsor

Sponsor

Financial Year

31-Dec-2018

Quarter

30-Jun-2018 [#2]

Profit Trend

QoQ- -34.66%

YoY- -19.21%

Quarter Report

PHARMA's Financial Summary

View:

Show?

YoY %

Horiz. %

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Annualized Quarter Result
Revenue	3,941,244	2,931,368	2,775,996	2,401,304	2,272,522	2,181,982	1,969,498	12.24%
YoY %	34.45%	5.60%	15.60%	5.67%	4.15%	10.79%	-	-
Horiz. %	200.11%	148.84%	140.95%	121.92%	115.39%	110.79%	100.00%	-
PBT	107,536	90,412	85,448	81,354	75,854	96,050	127,336	-2.77%
YoY %	18.94%	5.81%	5.03%	7.25%	-21.03%	-24.57%	-	-
Horiz. %	84.45%	71.00%	67.10%	63.89%	59.57%	75.43%	100.00%	-
Tax	-34,104	-26,368	-27,628	-34,644	-17,836	-27,828	-30,200	2.04%
YoY %	-29.34%	4.56%	20.25%	-94.24%	35.91%	7.85%	-	-
Horiz. %	112.93%	87.31%	91.48%	114.72%	59.06%	92.15%	100.00%	-
NP	73,432	64,044	57,820	46,710	58,018	68,222	97,136	-4.55%
YoY %	14.66%	10.76%	23.79%	-19.49%	-14.96%	-29.77%	-	-
Horiz. %	75.60%	65.93%	59.52%	48.09%	59.73%	70.23%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
NP to SH	73,680	64,756	57,796	45,960	56,886	66,748	96,022	-4.31%
YoY %	13.78%	12.04%	25.75%	-19.21%	-14.77%	-30.49%	-	-
Horiz. %	76.73%	67.44%	60.19%	47.86%	59.24%	69.51%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
Tax Rate	31.71%	29.16%	32.33%	42.58%	23.51%	28.97%	23.72%	-
YoY %	8.74%	-9.81%	-24.07%	81.11%	-18.85%	22.13%	-	-
Horiz. %	133.68%	122.93%	136.30%	179.51%	99.11%	122.13%	100.00%	-
Total Cost	3,867,812	2,867,324	2,718,176	2,354,594	2,214,504	2,113,760	1,872,362	12.84%
YoY %	34.89%	5.49%	15.44%	6.33%	4.77%	12.89%	-	-
Horiz. %	206.57%	153.14%	145.17%	125.76%	118.27%	112.89%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
Net Worth	357,275	357,891	518,564	519,642	541,894	524,041	527,991	-6.29%
YoY %	-0.17%	-30.98%	-0.21%	-4.11%	3.41%	-0.75%	-	-
Horiz. %	67.67%	67.78%	98.21%	98.42%	102.63%	99.25%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Dividend
Div	60,200	44,409	44,299	46,767	41,484	46,604	72,469	-3.04%
YoY %	35.56%	0.25%	-5.28%	12.74%	-10.99%	-35.69%	-	-
Horiz. %	83.07%	61.28%	61.13%	64.53%	57.24%	64.31%	100.00%	-
Div Payout %	81.71%	68.58%	76.65%	101.76%	72.93%	69.82%	75.47%	-
YoY %	19.15%	-10.53%	-24.68%	39.53%	4.45%	-7.49%	-	-
Horiz. %	108.27%	90.87%	101.56%	134.84%	96.63%	92.51%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Equity
Net Worth	357,275	357,891	518,564	519,642	541,894	524,041	527,991	-6.29%
YoY %	-0.17%	-30.98%	-0.21%	-4.11%	3.41%	-0.75%	-	-
Horiz. %	67.67%	67.78%	98.21%	98.42%	102.63%	99.25%	100.00%	-
NOSH	261,991	261,705	261,229	259,821	259,279	258,913	258,819	0.20%
YoY %	0.11%	0.18%	0.54%	0.21%	0.14%	0.04%	-	-
Horiz. %	101.23%	101.12%	100.93%	100.39%	100.18%	100.04%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Ratio Analysis
NP Margin	1.86%	2.18%	2.08%	1.95%	2.55%	3.13%	4.93%	-
YoY %	-14.68%	4.81%	6.67%	-23.53%	-18.53%	-36.51%	-	-
Horiz. %	37.73%	44.22%	42.19%	39.55%	51.72%	63.49%	100.00%	-
ROE	20.62%	18.09%	11.15%	8.84%	10.50%	12.74%	18.19%	-
YoY %	13.99%	62.24%	26.13%	-15.81%	-17.58%	-29.96%	-	-
Horiz. %	113.36%	99.45%	61.30%	48.60%	57.72%	70.04%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Per Share
RPS	301.16	1,122.12	1,065.29	924.21	876.47	842.74	760.95	-14.30%
YoY %	-73.16%	5.33%	15.26%	5.45%	4.00%	10.75%	-	-
Horiz. %	39.58%	147.46%	139.99%	121.45%	115.18%	110.75%	100.00%	-
EPS	5.64	24.78	22.18	17.68	21.94	25.78	37.10	-26.92%
YoY %	-77.24%	11.72%	25.45%	-19.42%	-14.90%	-30.51%	-	-
Horiz. %	15.20%	66.79%	59.78%	47.65%	59.14%	69.49%	100.00%	-
DPS	4.60	17.00	17.00	18.00	16.00	18.00	28.00	-25.97%
YoY %	-72.94%	0.00%	-5.56%	12.50%	-11.11%	-35.71%	-	-
Horiz. %	16.43%	60.71%	60.71%	64.29%	57.14%	64.29%	100.00%	-
NAPS	0.273	1.37	1.99	2.00	2.09	2.024	2.04	-28.45%
YoY %	-80.07%	-31.16%	-0.50%	-4.31%	3.26%	-0.78%	-	-
Horiz. %	13.38%	67.16%	97.55%	98.04%	102.45%	99.22%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Adjusted Per Share Value based on latest NOSH - 259,821
RPS	273.46	203.39	192.61	166.61	157.68	151.40	136.65	12.24%
YoY %	34.45%	5.60%	15.61%	5.66%	4.15%	10.79%	-	-
Horiz. %	200.12%	148.84%	140.95%	121.92%	115.39%	110.79%	100.00%	-
EPS	5.11	4.49	4.01	3.19	3.95	4.63	6.66	-4.31%
YoY %	13.81%	11.97%	25.71%	-19.24%	-14.69%	-30.48%	-	-
Horiz. %	76.73%	67.42%	60.21%	47.90%	59.31%	69.52%	100.00%	-
DPS	4.18	3.08	3.07	3.24	2.88	3.23	5.03	-3.03%
YoY %	35.71%	0.33%	-5.25%	12.50%	-10.84%	-35.79%	-	-
Horiz. %	83.10%	61.23%	61.03%	64.41%	57.26%	64.21%	100.00%	-
NAPS	0.2479	0.2483	0.3598	0.3606	0.376	0.3636	0.3663	-6.29%
YoY %	-0.16%	-30.99%	-0.22%	-4.10%	3.41%	-0.74%	-	-
Horiz. %	67.68%	67.79%	98.23%	98.44%	102.65%	99.26%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Price Multiplier on Financial Quarter End Date
Date	30/06/21	30/06/20	28/06/19	29/06/18	30/06/17	30/06/16	30/06/15	-
Price	5.29	2.22	2.84	2.88	4.58	5.50	7.13	-
P/RPS	1.76	0.20	0.27	0.31	0.52	0.65	0.94	11.00%
YoY %	780.00%	-25.93%	-12.90%	-40.38%	-20.00%	-30.85%	-	-
Horiz. %	187.23%	21.28%	28.72%	32.98%	55.32%	69.15%	100.00%	-
P/EPS	93.96	8.96	12.80	16.28	20.88	21.33	19.22	30.24%
YoY %	948.66%	-30.00%	-21.38%	-22.03%	-2.11%	10.98%	-	-
Horiz. %	488.87%	46.62%	66.60%	84.70%	108.64%	110.98%	100.00%	-
EY	1.06	11.17	7.81	6.14	4.79	4.69	5.20	-23.26%
YoY %	-90.51%	43.02%	27.20%	28.18%	2.13%	-9.81%	-	-
Horiz. %	20.38%	214.81%	150.19%	118.08%	92.12%	90.19%	100.00%	-
DY	0.87	7.66	5.99	6.25	3.49	3.27	3.93	-22.20%
YoY %	-88.64%	27.88%	-4.16%	79.08%	6.73%	-16.79%	-	-
Horiz. %	22.14%	194.91%	152.42%	159.03%	88.80%	83.21%	100.00%	-
P/NAPS	19.38	1.62	1.43	1.44	2.19	2.72	3.50	32.97%
YoY %	1,096.30%	13.29%	-0.69%	-34.25%	-19.49%	-22.29%	-	-
Horiz. %	553.71%	46.29%	40.86%	41.14%	62.57%	77.71%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Price Multiplier on Announcement Date
Date	20/08/21	19/08/20	23/08/19	17/08/18	16/08/17	19/08/16	17/08/15	-
Price	0.925	4.42	2.66	3.11	4.19	5.62	5.65	-
P/RPS	0.31	0.39	0.25	0.34	0.48	0.67	0.74	-13.48%
YoY %	-20.51%	56.00%	-26.47%	-29.17%	-28.36%	-9.46%	-	-
Horiz. %	41.89%	52.70%	33.78%	45.95%	64.86%	90.54%	100.00%	-
P/EPS	16.43	17.83	11.99	17.58	19.10	21.80	15.23	1.27%
YoY %	-7.85%	48.71%	-31.80%	-7.96%	-12.39%	43.14%	-	-
Horiz. %	107.88%	117.07%	78.73%	115.43%	125.41%	143.14%	100.00%	-
EY	6.09	5.61	8.34	5.69	5.24	4.59	6.57	-1.25%
YoY %	8.56%	-32.73%	46.57%	8.59%	14.16%	-30.14%	-	-
Horiz. %	92.69%	85.39%	126.94%	86.61%	79.76%	69.86%	100.00%	-
DY	4.97	3.85	6.39	5.79	3.82	3.20	4.96	0.03%
YoY %	29.09%	-39.75%	10.36%	51.57%	19.37%	-35.48%	-	-
Horiz. %	100.20%	77.62%	128.83%	116.73%	77.02%	64.52%	100.00%	-
P/NAPS	3.39	3.23	1.34	1.56	2.00	2.78	2.77	3.42%
YoY %	4.95%	141.04%	-14.10%	-22.00%	-28.06%	0.36%	-	-
Horiz. %	122.38%	116.61%	48.38%	56.32%	72.20%	100.36%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 0 of 0 comments

Featured Posts

Moomoo MY

Don't Miss Out: Up to USD1,000 in Our Lucky Draw!

Latest Videos

MQ Market Updates - 15 May 2024

MQ Trader

MQ Trading Signals

2024-05-16 15:00:00

EMA 5

Hourly

BUY

2024-05-16 12:00:00

EMA 5

30 Mins

BUY

2024-05-16 11:50:00

EMA 5

10 Mins

BUY

2024-05-16 11:45:00

EMA 5

5 Mins

BUY

2024-05-16 11:45:00

ADX

5 Mins

BUY

More Trading Signals

Apps

MQ Chat

Send individual or group chats with anyone on i3investor

MQ Trader

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

MQdemy

Online learning and teaching marketplace

Hot Stocks Today >

TOPGLOV

TOP GLOVE CORPORATION BHD

1000

TASCO

TASCO BERHAD

634

HARTA

HARTALEGA HOLDINGS BHD

567

MPI

MALAYSIAN PACIFIC INDUSTRIES

431

PTRANS

PERAK TRANSIT BERHAD

422

HLIND

HONG LEONG INDUSTRIES BHD

414

YTLPOWR

YTL POWER INTERNATIONAL BHD

411

MYEG

MY E.G. SERVICES BHD

378

MBSB

MALAYSIA BUILDING SOCIETY BHD

337

SUPERMX

SUPERMAX CORPORATION BHD

318

Daily Stocks

HSI-CXG

0.23

+0.025

278,390,300

REVENUE

0.235

-0.01

271,622,200

TOPGLOV

1.18

-0.08

249,719,900

HSI-HUZ

0.205

-0.04

232,343,800

MQTECH

0.015

-0.005

156,871,100

INIX-OR

0.02

0.00

141,839,900

CAREPLS

0.345

-0.035

95,258,600

MYEG

1.05

+0.02

87,058,500

SUPERMX

1.00

-0.08

84,953,200

SINKUNG

0.15

+0.01

83,425,600

More active Stocks

MPI

33.54

+1.02

156,100

F&N

33.24

+0.76

195,000

HEIM

24.80

+0.60

288,300

UTDPLT

26.20

+0.58

262,500

CARLSBG

20.12

+0.50

337,300

NESTLE

129.50

+0.50

27,300

ALLIANZ

22.06

+0.38

31,100

PANAMY

19.62

+0.36

16,200

KSENG

6.31

+0.33

495,600

TOMEI

2.06

+0.32

3,217,800

More gainer Stocks

AJI

16.18

-0.38

195,900

AIRPORT

10.08

-0.32

22,524,900

HARTA

3.55

-0.27

31,164,000

KOSSAN

2.48

-0.26

18,987,200

DLADY

32.72

-0.22

2,100

KOSSAN-C60

0.585

-0.195

341,000

AHEALTH

2.92

-0.15

757,000

ICAP

3.31

-0.13

324,600

KUAISHO-C17

0.08

-0.12

58,800

HARTA-C1W

0.415

-0.10

1,230,700

More loser Stocks

Featured Advertisers / Partners

Top Brokers >

AmEquities

Affin Hwang

Rakuten Trade

Hong Leong Bank

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....

Read More